ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

SSI INVESTMENT MANAGEMENT LLC's Holding History (CIK: 0000938487)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 4,098,000 Value ($000) $6,025 Avg Close — Range —
Q3 2025
Shares 4,098,000 Value ($000) $6,735 Avg Close — Range —
Q2 2025
Shares 6,837,000 Value ($000) $8,881 Avg Close — Range —
Q1 2025
Shares 7,078,000 Value ($000) $8,150 Avg Close — Range —
Q4 2024
Shares 7,078,000 Value ($000) $7,524 Avg Close — Range —
Q3 2024
Shares 7,353,000 Value ($000) $8,596 Avg Close — Range —
Q2 2024
Shares 5,339,000 Value ($000) $5,753 Avg Close — Range —
Q1 2024
Shares 407,000 Value ($000) $383 Avg Close — Range —
Q4 2023
Shares 4,922,000 Value ($000) $4,836 Avg Close — Range —
Q3 2023
Shares 4,896,000 Value ($000) $4,517 Avg Close — Range —